I have spent the last 10 years of my life investigating psychedelics as novel treatments for mental health conditions. When ...

The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine. The order does not change the legal status of ...

Forbes Advisor has ranked the best online master’s in healthcare administration programs, evaluating hundreds of accredited, nonprofit colleges in the U.S. across factors including cost, student ...

President Trump has signed an executive order to ease research restrictions on psychedelics, including the drug ibogaine, which is used in some countries to treat post-traumatic stress disorder.

CAHME Announces the Reaccreditation of the University of the Incarnate Word’s Graduate Program in Health Administration, Master of Health Administration (MHA). Accreditation by CAHME signals that a ...

President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs." "The ...

The president’s executive order is intended to accelerate research into the compounds’ efficacy in treating mental health disorders like severe depression and PTSD. By Andrew Jacobs and Noah Daly ...

President Donald Trump is expected to sign an executive order in the coming days that will encourage more research into the psychedelic ibogaine, according to a person familiar with the order. The ...

A psychedelic used in some countries to treat post-traumatic stress disorder is expected to get a closer examination from the federal government on its safety and effectiveness, sources told CBS News.